Eva Renee Barnett - Jan 7, 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Chief Financial Officer
Signature
/s/ Eva Renee Barnett
Stock symbol
IMVT
Transactions as of
Jan 7, 2022
Transactions value $
-$217,203
Form type
4
Date filed
1/11/2022, 09:53 AM
Previous filing
Oct 18, 2021
Next filing
Aug 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Sale -$217K -30K -14.79% $7.25 173K Jan 7, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 4, 2021, the holder was granted 59,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on October 5, 2021. These RSUs vested in their entirety on January 1, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs.